ArticleThe oncologist2024

Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer.

Yingqi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.